Achillion Pharmaceuticals, Inc. (NASDAQ:ACHN) Posted Basic Consolidated EPS Of $-0.0401

0

Achillion Pharmaceuticals, Inc. (NASDAQ:ACHN) annual basic consolidated EPS was $-0.0401 for the period ended 2015-12-31. The basic consolidated EPS was $-0.0401 for the quarter ended 2015-12-31.

EPS from continuing operations

Achillion Pharmaceuticals, Inc. (NASDAQ:ACHN)’s basic EPS from continuing operations was $-0.0401 for the fiscal year 2015-12-31. For the quarter ended 2015-12-31 it stood at $-0.0401

EPS contribution from parent

From the parent company Achillion Pharmaceuticals, Inc. (NASDAQ:ACHN) posted basic EPS of $-0.0401 for the fiscal ended 2015-12-31. For the quarter that ended on 2015-12-31 the figure stood at $-0.0401.

Basic net EPS

The Basic net EPS of Achillion Pharmaceuticals, Inc. (NASDAQ:ACHN) was $-0.04 for the period ended 2015-12-31. The figure stood at $-0.04 for the quarter that ended 2015-12-31.

Consolidated diluted EPS

The consolidated diluted EPS for the fiscal year 2015-12-31 stood at $-0.0401. While the figure for the quarter ended 2015-12-31 stood at $-0.0401.

Basic diluted EPS

The diluted EPS from continuing operation of Achillion Pharmaceuticals, Inc. (NASDAQ:ACHN) stood at $-0.0401 for the fiscal 2015-12-31. The figure for the quarter ended 2015-12-31 stood at $-0.0401

Net diluted EPS

The Net diluted EPS was $-0.04 for the fiscal 2015-12-31. The figure for the quarter ended 2015-12-31 stood at $-0.04.

Diluted EPS from parent

Achillion Pharmaceuticals, Inc. (NASDAQ:ACHN) diluted EPS from the parent company for the fiscal 2015-12-31 was $-0.0401. The figure for the quarter ended 2015-12-31 was $-0.0401

The net basic EPS was $-0.04 for fiscal 2015-12-31. The figure for the quarter ended 2015-12-31 was $-0.04

1 Chart Pattern Every Investor Should Know

This little-known pattern preceded moves of 578% in ARWR, 562% in LCI, 513% in ICPT, 439% in EGRX, 408% in ADDUS and more...

Click Here to See This Now.

(Visited 8 times, 1 visits today)